Docetaxel Injection

122 interactions 842 cited references
Also sold as: Beizray Docefrez® Docivyx Taxotere®
About Docetaxel Injection

Docetaxel injection is used alone or in combination with other medications to treat certain types of breast, lung, prostate, stomach, and head and neck cancers. Docetaxel injection is in a class of medications called taxanes. It works by stopping the growth and spread of cancer cells. Read the full Docetaxel Injection drug information page →

Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 10, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Yellow Fever Vaccine Mifepristone Measles Virus Vaccine, Live Levoketoconazole Ensitrelvir Dengue Tetravalent Vaccine, Live
12 Contraindicated 99 Major 9 Moderate 2 Minor
All (122) Contraindicated (12) Major (99) Moderate (9) Minor (2)

Contraindicated

Docetaxel Injection Bacillus Of Calmette And Guerin Vaccine, Live An increased risk of infection by the live vaccine Details Docetaxel Injection Dengue Tetravalent Vaccine, Live An increased risk of infection by the live vaccine Details Docetaxel Injection Ensitrelvir Increased CYP3A substrates exposure and an increased risk of CYP3A substrates-related adverse effects Details Docetaxel Injection Levoketoconazole Recorlev Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Docetaxel Injection Measles Virus Vaccine, Live An increased risk of infection by the live vaccine Details Docetaxel Injection Mifepristone Korlym Increased CYP3A4 substrate with NTI exposure Details Docetaxel Injection Mumps Virus Vaccine, Live An increased risk of infection by the live vaccine Details Docetaxel Injection Rubella Virus Vaccine, Live An increased risk of infection by the live vaccine Details Docetaxel Injection Smallpox Monkeypox Vaccine An increased risk of infection by the live vaccine Details Docetaxel Injection Typhoid Vaccine Typhim VI® An increased risk of infection by the live vaccine Details Docetaxel Injection Varicella Virus Vaccine, Live An increased risk of infection by the live vaccine Details Docetaxel Injection Yellow Fever Vaccine Stamaril An increased risk of infection by the live vaccine Details

Major

Docetaxel Injection Abametapir Increased exposure of CYP3A4 substrate Details Docetaxel Injection Adagrasib Krazati Increased DOCEtaxel exposure Details Docetaxel Injection Adenovirus Vaccine Type 4, Live An increased risk of infection by the live vaccine Details Docetaxel Injection Adenovirus Vaccine Type 7, Live An increased risk of infection by the live vaccine Details Docetaxel Injection Amiodarone Nexterone Increase in docetaxel exposure and risk of toxicity Details Docetaxel Injection Apalutamide Erleada Reduced OATP1B1/CYP3A4 substrate exposure Details Docetaxel Injection Aprepitant Aponvie Increased chemotherapeutic agent exposure Details Docetaxel Injection Asciminib Scemblix Increased CYP3A4 exposure and an increased risk of CYP3A4-related adverse reactions Details Docetaxel Injection Atazanavir Reyataz An increased risk of DOCEtaxel exposure Details Docetaxel Injection Avacopan Tavneos Increased exposure to CYP3A4 substrate Details Docetaxel Injection Belumosudil Rezurock Increased OATP1B1 substrate exposure Details Docetaxel Injection Belzutifan Welireg Reduced CYP3A4 substrates with NTI exposure and reduced efficacy of CYP3A4 substrates with NTI Details Docetaxel Injection Berotralstat Orladeyo Increased CYP3A4 substrate exposure and an increased CYP3A4 substrate-related adverse reactions Details Docetaxel Injection Boceprevir Increased DOCEtaxel exposure Details Docetaxel Injection Carbamazepine Carbatrol Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Docetaxel Injection Ceritinib Zykadia Increased exposure of CYP3A substrate Details Docetaxel Injection Cholera Vaccine Ipol An increased risk of infection by the live vaccine Details Docetaxel Injection Clarithromycin Biaxin Increased DOCEtaxel exposure Details Docetaxel Injection Cobicistat Tybost Increased DOCEtaxel exposure Details Docetaxel Injection Conivaptan Vaprisol Increased CYP3A substrate exposure Details Docetaxel Injection Crizotinib Xalkori Increased exposure of the CYP3A substrate Details Docetaxel Injection Daridorexant Increased CYP3A4 substrate with NTI exposure Details Docetaxel Injection Darolutamide Nubeqa Increased exposure of OATP1B1 or OATP1B3 substrates Details Docetaxel Injection Dronedarone Multaq An increased exposure to docetaxel Details Docetaxel Injection Ebola Zaire Vaccine, Live An increased risk of infection by the live vaccine Details Docetaxel Injection Elexacaftor Increased OATP1B1/OATP1B3 substrate exposure Details Docetaxel Injection Elinzanetant Lynkuet Increased CYP3A4 substrate with NTI exposure and an increased CYP3A4 substrate with NTI-related adverse reactions Details Docetaxel Injection Eltrombopag Alvaiz Increased OATP1B1 substrates exposure and an increased risk of OATP1B1 substrates-related adverse reactions Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.